Top compounds associated with response to TMEM239


Feature Type Standardized
Nominal ANOVA
mRNA TAE684 CTRPv2 pan-cancer AAC 0.13 0.0001
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.001
mRNA decitabine CTRPv2 pan-cancer AAC -0.086 0.001
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.081 0.003
mRNA JQ-1:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.094 0.005
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.093 0.005
mRNA salermide CTRPv2 pan-cancer AAC -0.12 0.01
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.085 0.01
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.081 0.01
mRNA GSK525762A CTRPv2 pan-cancer AAC -0.071 0.01
Download CSV